NCT06066333 2026-04-15
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Clinical Trials
3 trialsNCT06006013 2026-02-18
Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer
Emory University
Phase 2 Recruiting
NCT05563467 2025-04-02
PEMBR-01
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Recruiting